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Abstract
Purpose—To examine anthropometric and maturational characteristics at diagnosis in pediatric 
idiopathic intracranial hypertension (IIH).
Design—Retrospective, international, multisite study.
Participants—Pediatric patients (2–18 years of age at diagnosis) with IIH.
Main Outcome Measures—Body mass index (BMI), height, and weight Z-scores; sexual 
maturation.
Methods—Cases of IIH were identified retrospectively based on diagnostic code, pediatric 
neuroophthalmologist databases, or both and updated diagnostic criteria (2013) were applied to 
confirm definite IIH. Anthropometric measurements were converted into age- and gender-specific 
height, weight, and BMI Z-scores CDC 2000 growth charts. When available, sexual maturation 
was noted.
Results—Two hundred thirty-three cases of definite IIH were identified across 8 sites. In boys, a 
moderate association between age and BMI Z-scores was noted (Pearson’s correlation coefficient, 
0.50; 95% confidence interval [CI], 0.30–0.66; P < 0.001; n = 72), and in girls, a weak association 
was noted (Pearson’s correlation coefficient, 0.34; 95% CI, 0.20–0.47; P < 0.001; n = 161). The 
average patient was more likely to be overweight at diagnosis at age 6.7 years in girls and 8.7 
years in boys, and obese at diagnosis at age 12.5 years in girls and 12.4 years in boys. Compared 
with age- and gender-matched reference values, early adolescent patients were taller for age (P = 
0.002 in girls and P = 0.02 in boys). Data on Tanner staging, menarchal status, or both were 
available in 25% of cases (n = 57/233). Prepubertal participants (n = 12) had lower average BMI 
Z-scores (0.95±1.98) compared with pubertal participants (n = 45; 1.92±0.60), but this result did 
not reach statistical significance (P = 0.09).
Conclusions—With updated diagnostic criteria and pediatric-specific assessments, the present 
study identifies 3 subgroups of pediatric IIH: a young group that is not overweight, an early 
adolescent group that is either overweight or obese, and a late adolescent group that is mostly 
obese. Data also suggest that the early adolescent group with IIH may be taller than age- and 
gender-matched reference values. Understanding these features of pediatric IIH may help to 
illuminate the complex pathogenesis of this condition.
Pseudotumor cerebri syndrome encompasses the constellation of symptoms caused by 
elevated intracranial pressure of unclear cause with normal brain parenchyma and 
cerebrospinal fluid constituents.1 When there is no identifiable secondary cause of 
pseudotumor cerebri syndrome, such as prior exposure to tetracyclines or vitamin A, the 
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condition is termed primary pseudotumor cerebri syndrome or idiopathic intracranial 
hypertension (IIH).1 Idiopathic intracranial hypertension can occur in both pediatric and 
adult populations. Pediatric IIH shares some, but not all, features of adult IIH. Previous 
studies have suggested an influence of age, gender, and pubertal status on the epidemiologic 
features of pediatric IIH.2–6 Both female gender and obesity seem to be associated more 
strongly with IIH in older, but not younger, pediatric patients.2,7 In addition, the clinical 
presentation of pediatric IIH also may vary with age, with a greater number of young 
children presenting after a routine encounter without symptoms as compared with 
adolescents.2,5,8
Previous studies examining the role of excess body weight in the presentation of pediatric 
IIH were limited by the lack of standardized, pediatric-appropriate measurements. For 
example, investigators have described the relationship between body weight and IIH by 
defining obesity based on percentage of ideal body weight.2 The United States Centers for 
Disease Control and Prevention (CDC) defines pediatric obesity based on body mass index 
(BMI) and, more specifically, BMI percentiles or Z-scores.9 Unlike adults, definitions of 
being overweight and obese in children are not defined by absolute BMI because this varies 
with age. Rather, the CDC uses BMI percentiles or Z-scores in the pediatric population: a 
BMI percentile of 85% or more (equivalent BMI Z-score, ≥1.04) is considered overweight, 
whereas a BMI percentile of 95% or more (equivalent BMI Z-score, ≥1.64) is considered 
obese.9
Pubertal status also may contribute to the presentation and prognosis of this condition. 
Indeed, it has been suggested that children diagnosed with IIH when they are within their 
pubertal years (estimated as 11–14 years of age) are less likely to obtain excellent visual 
outcomes.6 Some previous studies examining the influence of pubertal status on the 
presentation of pediatric IIH also have assumed that all children younger than certain age 
threshold were prepubertal (e.g., patients younger than 11 years in one study).5 Given the 
wide range of typical ages at pubertal onset in children, pubertal status should be measured 
explicitly when attempting to evaluate its role in pediatric IIH. Pubertal status is ascertained 
most accurately by the development of secondary sexual characteristics (i.e., breast 
development in girls and testicular enlargement in boys).10,11
The purposes of this study were (1) to identify and confirm cases of pediatric IIH through 
consistent and rigorous application of the recently revised diagnostic criteria1 and (2) to 
examine the relationship between pediatric IIH, anthropometric features, and the 
development of secondary sexual characteristics. To address these issues, a multisite 
international study was undertaken to provide an adequate sample of pediatric patients with 
this relatively uncommon disorder.
Methods
This study was a retrospective chart review involving 8 international tertiary medical centers 
with expertise in pediatric IIH. Institutional review board/ethics committee approval was 
obtained by each site. The data coordinating center was located at The Children’s Hospital 
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of Philadelphia. This protocol was approved by the Institutional Review Board at The 
Children’s Hospital of Philadelphia (no. 13-010158).
At each site, patient charts were identified via an electronic medical record search for 
International Classification of Diseases, Ninth Edition, code 348.2, physician patient 
databases, or both. For this pediatric study, only patients 2 to 18 years of age at diagnosis 
were included in the study because we considered the pathophysiologic features of this 
diagnosis in infancy to be distinct. Retrospective data were collected on patients seen 
between July 1993 and April 2013 for all sites except for the University of Arkansas, where 
data were collected between July 1993 and December 2014. Cases of definite IIH were 
verified through manual chart review according to the revised diagnostic criteria for IIH.1 
Cases that did not fulfill all of the criteria for definite IIH were not included in the study. 
Reasons for exclusion were (1) medical records lacking details of diagnostic studies (e.g., 
lumbar punctures not completed, cerebrospinal fluid results or opening pressure not 
recorded) or (2) magnetic resonance venography studies were not performed for atypical 
patients (i.e., boys, nonobese girls). Although venogram studies were necessary for many 
cases of IIH, so-called typical IIH patients (i.e., obese and female) did not require a 
magnetic resonance venography study for inclusion.1 Cases were not included if there was a 
confirmed or suspected cause of secondary pseudotumor cerebri syndrome, aside from 
obesity, such as tetracycline use. Only patients fulfilling all diagnostic criteria for definite 
IIH were collected and included in subsequent analysis. Of note, patients fulfilling 
diagnostic criteria for probable IIH, that is, those patients who fulfilled all diagnostic criteria 
for definite IIH except for requirement of elevated opening pressure on lumbar puncture,1 
were not included in subsequent analysis.
In cases of definite IIH, age, gender, height measurements, and weight measurements at the 
time of diagnosis were collected. Pediatric obesity was defined using BMI Z-score. The 
BMI Z-scores were calculated from anthropometric data according to United States CDC 
2000 growth standards.9 According to the CDC, in children between 24 and 36 months of 
age, BMI Z-scores may be calculated based on stature, determined either by height or 
recumbent length. In our dataset, only 1 patient was younger than 36 months. In that patient, 
the method for determining stature is unknown. For all other patients, height was measured 
and documented. Overweight and obese were defined according to the CDC classifications 
of overweight (BMI Z-score, ≥1.04 and <1.64) and obese (BMI Z-score, ≥1.64) in children. 
Severe obesity was defined as the lower value of either BMI of 120% or more of the 95th 
percentile or more than 35 kg/m2.12 Study data were collected and managed using research 
electronic data capture tools13 hosted at The Children’s Hospital of Philadelphia.
Data on the development of secondary sexual characteristics were available in 57 patients 
with definite IIH. Data were collected on Tanner staging (breast, pubic hair, and testicular 
development, where appropriate14) as well as menarchal status, obtained within 3 months of 
diagnosis of IIH. Data were collected by patient self-report (menarchal status), after physical 
examination by a physician (Tanner stage), or both.15 Pubertal status was defined as 
prepubertal if there was a documented Tanner staging of 1 for breast or testicular volume in 
girls and boys, respectively. Pubertal status was defined as pubertal if there was documented 
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menarche, Tanner staging (breast) of 2 or more in girls, or both, or if testicular volume was 4 
ml or more in boys.
Pearson’s correlation analyses were used for examining the bivariate associations between 
normally distributed outcomes of interest. The relationships between anthropometric 
features and age were assessed using linear prediction models, with 95% confidence 
intervals (CIs). Analysis of the influence of gender on the anthropometric features of IIH 
was completed by linear regression analysis and chi-square testing. One-sample t tests were 
used to compare mean Z-scores against hypothesized mean Z-scores (e.g., of theoretical or 
actual age- and gender-matched reference values). Statistical significance was defined as a 2-
sided P value of <0.05. Analyses were performed in Stata software version 13.1 (Stata Corp, 
College Station, TX).
Results
In total, 233 cases of definite IIH were identified from 8 international sites. Participants had 
a mean age ± standard deviation of 12.1±4.0 years and were predominately girls (69% girls; 
n = 161). Participants had a mean ± standard deviation BMI Z-score of 1.55±1.18, which 
indicated the average body habitus as overweight according to the CDC definition in the 
pediatric population. Compared with girls, boys were younger and had lower BMI Z-scores 
(see Table 1). Pubertal data were available in 57 patients with definite IIH (Table 2).
In both boys and girls, we observed an overall positive relationship between age and BMI Z-
score at IIH diagnosis (Fig 1). Specifically in boys, a moderate association was noted 
(Pearson’s correlation coefficient, 0.50; 95% CI, 0.30–0.66; P < 0.001; n = 72), and in girls, 
a weak association was noted (Pearson’s correlation coefficient, 0.34; 95% CI, 0.20–0.47; P 
< 0.001; n = 161). In the youngest boys and girls with IIH, average BMI Z-score was within 
the normal range at diagnosis. After age 6.7 years in girls and 8.7 years in boys, the average 
BMI Z-score began to exceed 1.04, the threshold for overweight. After age 12.5 years in 
girls and 12.4 years in boys, the average BMI Z-score exceeded 1.64, the threshold for 
obesity. The proportion of boys decreased significantly with age at diagnosis of IIH (P < 
0.001); boys accounted for 64% (n = 27/42) of participants younger than 8 years, 32% (n = 
32/99) of participants 8 to 13 years of age, and 14% (n = 13/92) of participants older than 13 
years. We did not detect an influence of gender on the relationship between BMI Z-scores 
and age at diagnosis (test of interaction between gender and age on BMI-Z in linear 
regression model; P = 0.71). Overall, in younger age groups, BMI Z-score typically was not 
in the overweight or obese range. In contrast, mean BMI Z-score was in the overweight and 
obese ranges in participants at early and late adolescent ages. Stated differently, the 
proportion of participants with defined pediatric obesity (BMI Z-score, ≥1.64) increased 
with age in both girls and boys. In girls younger than 6.7 years, 22% of BMI Z-scores were 
1.64 or more (n = 2/9), whereas among girls between 6.7 and 12.5 years of age and among 
girls older than 12.5 years, 59% (n = 30/51) and 77% (n = 78/101) of BMI Z-scores, 
respectively, were 1.64 or more (P = 0.001). In boys younger than 8.7 years, 13% of BMI Z-
scores were 1.64 or more (n = 4/30), whereas among boys between 8.7 and 12.4 years of age 
and older than 12.4 years, 72% (n = 13/18) and 63% (n = 15/24) of BMI Z-scores, 
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respectively, were 1.64 or more (P < 0.0005). The proportion with severe obesity in boys 
was 28% (n = 20/72) and that in girls was 37% (n = 59/161; P = 0.19).
Thus, we have illustrated that there are distinct differences in the anthropometric features of 
pediatric participants with IIH, depending on the age of diagnosis. Body mass index reflects 
the relationship between weight and height, both of which change during puberty in 
complex ways that can depend on both gender and adiposity.16 To delineate better the role of 
growth patterns in pediatric IIH, we next considered height and weight Z-scores separately. 
We used gender-specific overweight and obese thresholds, as defined via the regression 
analyses in Figure 1. Based on the anthropometric features seen in this population of 
participants with pediatric IIH, these empirically determined age cutoffs helped to define 3 
subgroups of pediatric IIH. For girls, we considered children younger than 7 years, early 
adolescents between 7 and 12.5 years of age, and later adolescents 12.5 years of age or 
older. For boys, we considered children younger than 8.5 years, early adolescents between 
8.5 and 12.5 years of age, and later adolescents 12.5 years of age or older.
Illustrated with dot distribution plots, there were positive relationships between the defined 
age categories of IIH and both BMI Z-scores and weight Z-scores in both girls and boys (Fig 
2A, B). In contrast, height Z-scores were statistically higher in the early adolescent age 
category for both girls and boys when compared with the theoretical population average 
height Z-score of 0 (Fig 2C; by 1-sample t test). Compared with the observed average height 
Z-score of 0.2 in a nationally representative sample,17 height Z-values in the early 
adolescent group remained statistically significant when considering girls, and there was a 
trend for significance in boys (using 1-sample t test analyses to compare mean height Z-
scores against a predicted mean Z-score of 0.2017: in girls younger than 7 years, P = 0.47; in 
girls 7–12.5 years of age, P = 0.048; in girls older than 12.5 years, P = 0.01; in boys younger 
than 8.5 years, P = 0.88; in boys 8.5–12.5 years of age, P = 0.089; and in boys older than 
12.5 years, P = 0.29). These observations may indicate early linear growth acceleration in 
the early adolescent age group.
Pubertal data were available in 57 patients with definite IIH, representing 25% of the total 
number of patients accrued. We applied standardized definitions of pubertal status, obtained 
within 3 months of diagnosis of IIH. As outlined in Table 2, 21% (n = 12) were prepubertal 
and 79% (n = 45) were pubertal at the time of the diagnosis of IIH. Compared with the 
prepubertal population, BMI Z-scores and weight Z-scores were higher in the pubertal 
population, but did not reach statistical significance in this small subsample. Conversely, 
height Z-scores were not statistically different between prepubertal and pubertal groups. 
Pubertal status may influence anthropometric features at presentation of pediatric IIH, 
although a careful prospective collection of pubertal stage information would be needed to 
establish this in a larger sample.
Discussion
In this study, we used pediatric-specific standards to examine the influence of 
anthropometric features and sexual maturation on the development of pediatric IIH. We 
included more than 200 clinical cases of definite IIH using the recently revised criteria for 
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IIH.1 To our knowledge, this is the largest study examining clinical characteristics at 
presentation of pediatric IIH. Moreover, height and weight measurements were collected 
from the electronic medical record, and the subanalysis of pubertal status was based on 
physical examination data by physicians. The CDC recommends the use of BMI Z-values or 
BMI percentile values to define excess weight in children. In this study, BMI Z-values were 
used as the metric of pediatric weight status. In contrast to BMI percentile, BMI Z-score is a 
continuous variable that limits clustering of data points at higher values and lends itself to 
further statistical analysis, including regression plots.
Previous studies on the influence of anthropometric features and pubertal status on IIH have 
been limited. First, many did not apply pediatric-specific measurements of anthropometric 
features.2 Moreover, there are also gender differences to consider in the pediatric population, 
with specific BMI growth curves for boys and girls.9 A recent study into the anthropometric 
features of pediatric IIH did use appropriate BMI percentiles to characterize the frequency of 
overweight and obesity features in the pediatric population with IIH, with overall 
directionally similar findings.18 However, IIH diagnoses were supported using former 
diagnostic criteria for pediatric IIH,18 in contrast to the application of the recently revised 
criteria used in the present study.1 In the present, larger study, we assembled a cohort from a 
diverse range of sites and included more detailed analyses of height. Finally, previous 
studies examining the influence of pubertal status on the presentation of IIH have used age-
dependent assumptions of puberty,5,6 which do not account for the wide range of 
physiologic variation in pubertal timing. The use of arbitrary cutoff values may lead to 
limited insights, and in the present study, we included a subanalysis of directly measured 
pubertal stage.
This study thus confirms and extends previous insights into pediatric IIH. We confirmed that 
there is a positive relationship between BMI Z-score and age at diagnosis of pediatric IIH. 
Using standardized definitions of pediatric obesity accepted at that time, Balcer et al2 
evaluated anthropometric data from 40 participants and illustrated the presence of 2 distinct 
populations of pediatric IIH, namely a younger, equally male and female population and an 
older, predominately obese and female population. Other studies have illustrated similar 
findings.18 The present study does support an increasing prevalence of pediatric obesity in 
older children with IIH. We also identified that the proportion of boys is higher at younger 
age groups; however, there is no significant effect of gender on the relationship between 
BMI Z-score and age at diagnosis of IIH.
Our study revealed a new observation that there are multiple subgroups of pediatric IIH as 
defined by anthropometric thresholds of overweight and obesity features. Specifically, in 
young children (less than approximately 7 years of age in girls and less than 8.5 years of age 
in boys), BMI and height Z-scores are similar to age- and gender-based reference standards. 
In early adolescence, BMI Z-scores cluster between the overweight and obese thresholds, 
whereas height Z-scores are greater than age and gender-matched reference standards. 
Finally, in late adolescence (older than approximately 12.5 years of age in girls and boys), 
average BMI Z-scores are well above the overweight and obese thresholds, and height Z-
scores again are similar to age- and gender-matched reference standards. In this cross-
sectional study, it remains unclear if these 3 subgroups indicate an underlying progression of 
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pediatric IIH or if these represent distinct subgroups of the disease with unique clinical 
features and, possibly, underlying pathophysiology. It is also unclear if these 3 subgroups are 
defined best by anthropometric features, as completed in this study, or if other 
developmental processes, possibly the development of secondary sexual characteristics, 
better define these groups. Further longitudinal studies that include explicit measurements of 
secondary sexual characteristics are required to extend these observations. Moreover, further 
studies are also needed to determine whether an obesity-related linear growth acceleration, a 
feature seen in overweight pediatric participants without IIH, drives the taller stature in the 
early adolescent group.19,20
By characterizing subsets of pediatric IIH, the aim is that governing anthropometric features 
within each group may be defined. In turn, insights may be gained into potential endocrine 
foundations of this condition and, ultimately, an understanding of its overall pathogenesis. In 
prepubertal children younger than 8 years, we suggest that factors other than adiposity may 
contribute to the presentation of disease. Indeed, examples exist in the literature of 
secondary pediatric pseudotumor cerebri syndrome in nonobese participants. These include 
exposure to recombinant growth hormone for various conditions, including growth hormone 
deficiency, Turner syndrome, and renal disease,21,22 as well as pediatric participants with 
secondary aldosteronism, possibly related to renal structural or transport dysfunction (e.g., 
SLC12A3 gene mutation, renal congenital hypoplasia, or genetic renal tubular disorders).23 
In the present study, no evidence was found for these disorders on detailed review of the 
electronic records, but no consistent screening paradigm was applied. Development of an 
evidence-based screening paradigm for prepubertal children with pseudotumor cerebri 
syndrome may be an important focus of future investigations.
In the early and late adolescent subgroups, adiposity clearly is associated with IIH. Pediatric 
adiposity has complex pathophysiologic factors, and as such, many potential factors are 
likely contributing to the presentation of disease.24 The observation that there is a taller 
height Z-score in the early adolescent subgroup of pediatric IIH indicates that, at this age, 
participants are taller than age- and gender-matched reference standards. Increased adiposity 
has been associated with increased linear growth acceleration in early adolescence in 
otherwise healthy children.19,20 In general, obese children tend to grow quickly before 
puberty and may have less growth during puberty as a result. The possibility exists that the 
increased linear growth acceleration seen in the early adolescent population with IIH is 
reflecting effects of weight status and not clearly related to IIH per se. However, it may be 
that factors that influence linear growth acceleration in young adults with overweight and 
obese status also may influence the development of IIH. Indeed, the secretion and action of 
growth hormone has been posited to differ in obese individuals, and growth hormone has 
been implicated in the pathogenesis of pseudotumor cerebri syndrome.25,26 Gonadal 
hormones also may contribute to the pathogenesis of IIH, particularly in the early and late 
adolescent, and more likely pubertal, age groups. Indeed, exposure to exogenous (e.g., 
levonorgestrel27 and emergency contraceptives28) and endogenous (e.g., pregnancy29,30 and 
polycystic ovary syndrome31) estrogens have been associated with IIH. Moreover, increased 
androgens, namely basal testosterone and androstenedione, have been linked with a younger 
age at presentation of IIH in an adult female population.32 Prospective studies, including 
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measurements of adrenal and gonadal steroids, would be useful to understand how these 
affect IIH pathogenesis around the time of adrenarche and puberty.
Finally, in this study, data were obtained on pubertal status in one quarter of the cases 
analyzed. Our findings are consistent with previous suggestions that prepubertal participants 
are of normal weight, whereas participants who have entered puberty demonstrate higher 
BMI and weight Z-scores at the time of IIH diagnosis.2 These data are strengthened by the 
use of the documented Tanner staging, notation of menstrual status, or both. The most 
notable limitation is the incomplete information on pubertal status, making this set of 
secondary analyses more susceptible to selection bias. We clearly indicated pubertal status in 
the figures, such that the potential role of selection bias in the results obtained can be 
visualized directly.
Additional limitations to these data exist. We operated under the assumption that the data 
collected for the present study accurately represent the population of pediatric IIH as a 
whole. Retrospective studies are limited by incomplete medical records as well as recall and 
selection bias. Differences also may exist in data collection technique and documentation in 
a multisite study. However, in the present study, having collected more than 200 clinical 
cases of definite IIH, all from sites with expertise in this condition, and each case being 
rigorously vetted with standard case report forms, we do not anticipate that these differences 
would have produced systematic errors.
In summary, this study identified 3 subgroups of pediatric IIH based on anthropometric 
thresholds of pediatric overweight and obesity features. The present study also highlighted 
the importance of considering sexual maturation when investigating potential 
developmentally specific mechanisms of IIH. Defining key events that influence the risk for 
pediatric IIH and its relationship with obesity may provide insight into the endocrine factors 
that predispose individuals to this poorly understood condition.
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Figure 1. 
Dot distribution plots showing the relationship between body mass index (BMI) Z-score and 
age at diagnosis of pediatric idiopathic intracranial hypertension (IIH). In both girls and 
boys, there is a positive relationship between BMI Z-score and age at diagnosis of definite 
pediatric IIH. Specifically, in boys, a moderate association was noted (Pearson’s correlation 
coefficient, 0.50; 95% confidence interval [CI], 0.30–0.66; P < 0.001; n = 72), and in girls, a 
weak association was noted (Pearson’s correlation coefficient, 0.34; 95% CI, 0.20–0.47; P < 
0.001; n = 161). In both groups, the circles represent data obtained from individual 
participants, whereas the color of the circle represents pubertal status (“missing” indicates 
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that pubertal information was not available). The line represents the results of a linear 
regression of BMI-Z with 95% CIs of the mean (Stata software; Stata Corp, College Station, 
TX). Horizontal reference lines indicate the Centers for Disease Control and Prevention 
(CDC)-defined BMI Z-scores for overweight and obesity features in the pediatric 
population. The thin arrows indicate overweight thresholds and thick arrows indicate obese 
thresholds. The overweight threshold indicates the intersection between the plotted linear 
regression relationship and the BMI Z-score of 1.04 (CDC definition of overweight). The 
obese threshold indicates the intersection between the linear regression relationship and the 
BMI Z-score of 1.64 (CDC definition of obese). The overweight threshold occurred at 6.7 
years in girls and 8.7 years in boys. The obese threshold occurred at 12.5 years in girls and 
12.4 years in boys.
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Figure 2. 
Dot distribution plots showing the distinct differences in anthropometric features seen 
between defined age categories in participants with pediatric idiopathic intracranial 
hypertension (IIH). Distribution plots illustrate body mass index (BMI), weight, or height Z-
scores, seen in defined age categories of participants with pediatric IIH. The age cutoffs 
were defined empirically, using the regression analysis in Figure 1. For girls, the categories 
were young children younger than 7 years, early adolescents between 7 and 12.5 years of 
age, and older adolescents 12.5 years of age or older. For boys, the categories were young 
children younger than 8.5 years, early adolescents between 8.5 and 12.5 years of age, and 
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older adolescents 12.5 years of age or older. In both boys and girls with pediatric IIH, (A) 
BMI Z-scores and (B) weight Z-scores increased in older age categories (P = 0.0001 in girls 
and P < 0.0001 in boys, analysis of variance of BMI Z-scores; and P = 0.0015 in girls and P 
< 0.0001 in boys, analysis of variance of weight Z-scores). C, In girls and boys with 
pediatric IIH, only height Z-scores measured in the early adolescent categories were higher 
than the age- and gender-matched hypothesized values. Statistical comparisons used 1-way t 
test analyses to compare mean Z-scores against a hypothesized mean Z-score of 0.00 (e.g., 
age- and gender-matched normative data). In girls, P = 0.28 in those younger than 7 years, P 
= 0.004 in those 7 to 12.5 years, and P = 0.45 in those 12.5 years of age or older. In boys, P 
= 0.35 in those younger than 8.5 years, P = 0.03 in those 8.5 to 12.5 years, and P = 0.71 in 
those 12.5 years of age or older. In (A), (B), and (C), circles represent individual data points, 
whereas the color of the circle indicates pubertal status (“missing” indicates that pubertal 
information was not available). Boldface, dashed lines indicate mean values.
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Table 1
Pediatric Idiopathic Intracranial Hypertension Multicenter Cohort: Overall Demographic and Anthropometric 
Features of Patients
Girls Boys
Age (range) at
  presentation, yrs
13.1±3.5 (2.3–18.0) 9.95±4.14 (3.0–17.9)*
Height
  (Z-score), m
1.52±0.17 (0.17±1.29) 1.40±0.26 (0.25±1.35)†
Weight
  (Z-score), kg
72.6±29.1 (1.68±1.14) 54.6±38.8 (1.28±1.51)*
BMI
  (Z-score), kg/m2
30.2±9.6 (1.70±1.07) 24.7±11.4 (1.24±1.36)*
BMI = body mass index.
Values are means ± standard deviations unless otherwise indicated.
*P < 0.05.
†Not significant.
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Table 2
Pediatric Idiopathic Intracranial Hypertension Multisite Cohort: Comparison of Demographic and 
Anthropometric Features in Prepubertal and Pubertal Patients with Known Pubertal Status
Prepubertal
(n = 12)
Pubertal
(n = 45)
Not Reported
(n = 176)
Gender
  (girls:boys)
10:2 43:2 108:68
Age (yrs) 9.0±2.7 14.8±2.4 11.6±4.1
BMI Z-score 0.95±1.98 1.92±0.60* 1.51±1.21
Weight Z-score 0.73±2.12 1.89±0.71* 1.53±1.30
Height Z-score 0.13±1.60 0.03±1.24† 0.24±1.31
BMI = body mass index.
Values are means ± standard deviations unless otherwise indicated.
*P < 0.10, suggesting a possible association (F = 2.93, P =0.09 and F = 3.49, P = 0.07, when comparing BMI and weight Z-scores in prepubertal 
vs. pubertal subjects, analysis of variance).
†No statistically significant differences between height Z-scores seen in prepubertal vs. pubertal patients (F = 0.43, P = 0.51, analysis of variance).
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